Medication Burden In 3+Meds Glaucoma Eyes Following Canaloplasty Via An Ab-Interno Technique Combined With Phacoemulsification
Published 2024 - 42nd Congress of the ESCRS
Reference: PO980 | Type: Free paper | DOI: 10.82333/b5ty-d996
Authors: Jose Maria Martinez-De-La-Casa* 1 , David Lubeck 2 , Keith Barton 3 , Nathan Kerr 4
1Hospital Clinico San Carlos,Madrid,Spain, 2Arbor Centers for Eye Care,Homewood, IL,United States, 3Moorfields Eye Hospital,London,United Kingdom, 4Center for Eye Research Australia,East Melbourne, VIC,Australia
Purpose
To evaluate the effectiveness of 360-degree canaloplasty using iTrack microcatheter (Nova Eye Medical., Fremont, USA) in glaucoma patients on 3+ medications.
Setting
A prospective multicenter case series
Methods
Included are eyes undergoing canaloplasty either combined with cataract surgery or performed as a standalone procedure. Patients with glaucoma and on 3+ medications were included. Primary endpoints included intraocular pressure (IOP) and number of medications at 12 months.
Results
IOP (mmHg) and number of medications at baseline (n=127) were 17.4±5.37 and 3.46±0.59, which reduced to 14.1±4.86 (-19.3%; p<0.001) and 2.12±1.45 (-38.8%; p<0.001) at 12 months (n=41), respectively. Nine eyes (22.0%) were medication-free at 12 months. There was a reduction in number of medications in 22 eyes (53.7%; mean reduction: 2.55 meds); the other 19 eyes had no change in medications; no eye had an increase in medications. Twenty eyes (48.8%) still required the use of 3 or more medications.
Conclusions
Canaloplasty when combined with cataract surgery or performed as a standalone procedure reduced medication burden in eyes requiring 3 or more medications at baseline up to 12 months postoperatively.